Latest in Ozempic parent’s stock having worst day since the 1980s as new weight loss drug disappoints
Sort by
2,772 items
-
FDA approves weight loss drug Zepbound for sleep apnea
Zepbound, Eli Lilly’s weight loss drug, can now be used to treat obstructive sleep apnea in adults with obesity, the FDA said.NBC News - 1h -
FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S.
The agency's decision expands the use of Zepbound and could potentially pave the way for Eli Lilly to gain broader insurance coverage for the treatment.CNBC - 1h -
Eli Lilly given US approval to treat sleep disorder with weight-loss drug
Regulatory go-ahead marks latest boost for drugmaker’s blockbuster anti-obesity franchiseFinancial Times - 1h -
F.D.A. Approves Weight-Loss Drug to Treat Sleep Apnea
Zepbound is the first prescription drug approved specifically to treat the common condition.The New York Times - 2h -
Russia-Ukraine war live: Russia suffers worst daily losses since the start of the invasion, claims Ukraine
Kyiv says that 2,200 Russian soldiers have died in the last 24 hours. The Russian Defence Ministry said that its forces had taken control of two more settlements in Ukraine’s Donetsk region, ...The Guardian - 9h -
Ozempic parent’s stock having worst day since the 1980s as new weight-loss drug disappoints
Novo Nordisk’s stock dives as new weight loss drug disappoints in a late-stage trial, which gave a boost to Eli Lilly shares.MarketWatch - 9h -
Novo Nordisk shares tumble as weight-loss drug trial data disappoints
Obesity drug CagriSema misses goal of 25% body weight reductionFinancial Times - 12h -
Micron shares suffer steepest drop since 2020 after disappointing guidance
Micron's stock plummeted Thursday following the company's earnings report and its weaker-than-expected guidance for the second quarter.CNBC - 1d -
FDA says Eli Lilly's weight loss drug Zepbound is no longer in shortage
The decision that will eventually bar compounding pharmacies from making unbranded versions of the injection.CNBC - 1d -
Stocks rise, a day after disappointing forecast from Fed triggers sell-off
U.S. stocks are stabilizing following one of their worst days of the year.CBS News - 1d -
Micron’s stock may see its worst day since 2020. Why the bulls are still upbeat.
Analysts are largely upbeat on Micron’s stock, pointing to an upbeat AI narrative while noting that pressures on consumer markets shouldn’t be much shock to Wall Street.MarketWatch - 1d -
Weight Loss Drugs Changed Their Lives. Then They Lost Coverage.
In Michigan, the state’s largest insurer has tightened restrictions around medications like Wegovy. Patients are panicking.The New York Times - 1d -
FDA warns companies over unapproved weight loss drug sales
The Food and Drug Administration (FDA) said Tuesday in a statement it has sent warning letters to companies selling unapproved weight loss drugs. The letter went to Xcel Peptides, Swisschems, ...The Hill - 2d -
Tennessee woman accused of selling fake weight loss drugs as counterfeit concerns grow
A Tennessee woman was accused of selling counterfeit versions of popular weight loss drugs including Ozempic. Experts say fakes have exploded in the U.S.NBC News - 3d -
CVS’s stock seeing worst month in decades as drug seller gets criticism from both parties
Roles of drug “middlemen” are taking punches from the right by Donald Trump and from the left by Elizabeth Warren.MarketWatch - 3d -
These three new sports dramas punch above their weight
The sports movie, like any genre, can easily fall victim to overly familiar story beatsABC News - 3d -
Why the investor craze for Ozempic and rival weight-loss drugs may resume next year
Novo Nordisk’s takeover of Catalent and the Danish firm’s push to launch a new generation of drugs could boost the importance of GLP agonists in 2025, Barclays analysts saidMarketWatch - 4d -
Conan O’Brien’s Parents Die 3 Days Apart
Thomas O’Brien, an epidemiologist, and Ruth O’Brien, a lawyer, juggled successful careers with raising six children, including the comedy star.The New York Times - Dec. 13 -
In shift, RFK Jr. now says weight-loss drugs 'have a place'
His remarks come days before he holds confirmation meetings with GOP senators.ABC News - Dec. 12 -
Elon Musk contradicts RFK Jr.'s sentiments on weight loss drugs
Elon Musk validated the use of GLP-1 drugs in a post on X on Wednesday. But Robert F. Kennedy Jr. has said he's opposed to Americans using them to fight obesity.ABC News - Dec. 12 -
On Ozempic? Big Food Makers Have a New Label for You
Conagra Brands is adding “GLP-1 friendly” to packaging on Healthy Choice frozen meals to woo users of weight-loss drugs.The Wall Street Journal - Dec. 12 -
What other conditions could weight-loss drugs treat?
Initial research has focused on obesity, but Ozempic, Wegovy and Mounjaro may potentially be used for addiction, heart disease and Alzheimer’sFinancial Times - Dec. 12 -
Alphabet’s stock having best 2-day run in a decade as the good news keeps coming
Google parent Alphabet’s stock is having its best two-day run in nine years amid good news on the quantum-computing and Waymo fronts.MarketWatch - Dec. 11 -
Ro to offer lower-price vials of weight loss drug Zepbound by teaming up with Eli Lilly
It is made possible through a first-of-a-kind integration with Eli Lilly's direct-to-consumer website, and aims to streamline access to the popular treatment.CNBC - Dec. 11 -
Insurance stocks have fallen since UnitedHealthcare CEO killing
Major insurance stocks have fallen since their closing prices last Tuesday, the day before the deadly shooting of UnitedHealthcare CEO Brian Thompson.CNBC - Dec. 10 -
Walgreens’ stock on pace for its best day ever on report of talks of sale to private equity — but still on pace for its worst year
Shares of Walgreens Boots Alliance Inc. launched higher on Tuesday after the Wall Street Journal reported that the drugstore chain was in discussions to sell itself to private-equity firm Sycamore ...MarketWatch - Dec. 10 -
Beneath the hood, stocks just suffered their worst day of the year. Some are worried.
Momentum stocks quietly just had their worst day of the year. History points to a mixed experience when that happens.MarketWatch - Dec. 10 -
Some health experts warn against microdosing weight loss drugs
The demand for weight loss drugs, like Ozempic and Wegovy, has skyrocketed in the past few years despite the high cost and unpleasant side effects for some people. The New York Times reports some ...CBS News - Dec. 9 -
Mondelez is reportedly exploring a Hershey acquisition. Drugs like Ozempic could justify a deal.
Shares of Hershey Co. booked a double-digit percentage gain on Monday after Bloomberg reported that Oreo maker Mondelez International Inc. was exploring a possible acquisition of the iconic ...MarketWatch - Dec. 10 -
AppLovin’s S&P 500 snub makes for the stock’s worst day in 2 years
AppLovin’s $135 billion market cap and 900% year-to-date surge through Friday’s close weren’t enough to earn it entry into the benchmark large-cap index.MarketWatch - Dec. 9 -
Giants' latest 'disappointing' loss keeps hope of landing No. 1 pick alive
Graham Gano’s miss sealed the Giants’ 14-11 loss to the lowly Saints. More importantly: It kept the possibility of the No. 1 pick in the NFL Draft alive.Yahoo Sports - Dec. 9 -
The weight-loss drug boom has become one of the internet's biggest scams
As demand for obesity drugs like Wegovy, Zepbound, Mounjaro and Ozempic, outpaces supply, online scams are rising, according to cybersecurity experts.CNBC - Dec. 8 -
Weight-loss drug Mounjaro 'changed my life,' says mother-of-two
People struggling with their weight welcome the NHS rollout of Mounjaro but worry about delays.BBC News - Dec. 5 -
Prescription fills for weight loss drugs Zepbound and Wegovy more than doubled in 2024, GoodRx says
The jump in prescription fills comes despite limited insurance coverage and high out-of-pocket costs for Novo Nordisk's Wegovy and Eli Lilly's Zepbound.CNBC - Dec. 5 -
Millions will have to wait up to 12 years for NHS weight-loss drug
Fears that giving 3.4 million people immediate access to new weight-loss drug could overwhelm NHS.BBC News - Dec. 5 -
Will Trump nix Biden’s coverage plan for weight-loss drugs? It’ll be a close call.
While President-elect Donald Trump looks poised to scrap many policies of the Biden administration, one veteran analyst says it’s possible he could end up supporting the Democratic incumbent’s ...MarketWatch - Dec. 4 -
Zepbound brings more weight loss than Wegovy: Drugmaker
Adults who take Zepbound lose more weight than those who take competitor weight loss drug Wegovy, according to new clinical trial results. Zepound manufacturer Eli Lilly released results from their ...The Hill - Dec. 4 -
A rival weight loss drug to Wegovy helped people shed more pounds, study shows
People who took Zepbound, Eli Lilly’s weight loss drug, shed more pounds than those on Novo Nordisk’s Wegovy in a clinical trial, Lilly said in a release Wednesday.NBC News - Dec. 4 -
The teams that have impressed (TCU!) and disappointed (USC) one month into the season
From JuJu Watkins and USC to Paige Bueckers and UConn, we break down what's happened so far.ESPN - Dec. 4 -
Experts create controllable gastric balloon to aid weight loss
Device inflates before eating and contracts afterwards, simulating the effects of having a meal, say scientists. From weight loss jabs to vibrating pills , the obesity crisis has spawned myriad ...The Guardian - Dec. 3
